Thomas Jefferson University

Jefferson Digital Commons
Department of Pediatrics Faculty Papers

Department of Pediatrics

3-1-2011

The pulmonologist's role in caring for pregnant women with
regard to the reproductive risks of diagnostic radiological studies
or radiation therapy.
Robert Brent
Thomas Jefferson University

Follow this and additional works at: https://jdc.jefferson.edu/pedsfp
Part of the Bioethics and Medical Ethics Commons, and the Pediatrics Commons

Let us know how access to this document benefits you
Recommended Citation
Brent, Robert, "The pulmonologist's role in caring for pregnant women with regard to the
reproductive risks of diagnostic radiological studies or radiation therapy." (2011). Department of
Pediatrics Faculty Papers. Paper 35.
https://jdc.jefferson.edu/pedsfp/35
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Department of Pediatrics Faculty Papers by an authorized administrator of the Jefferson
Digital Commons. For more information, please contact: JeffersonDigitalCommons@jefferson.edu.

As submitted to:
Clinics in chest medicine
And later published as:
The Pulmonologist’s role in Caring for Pregnant Women
with Regard to the Reproductive Risks of Diagnostic
Radiologic Studies or Radiation Therapy.
Volume 32, Issue 1, Pages 33-42 (March 2011)
doi:10.1016/j.ccm.2010.10.002
by

Robert L Brent, MD, Ph.D., D.Sc. (Hon.)
Distinguished Professor of Pediatrics, Radiology, and Pathology
Louis and Bess Stein Prof. of Pediatrics
Thomas Jefferson University
Alfred I. duPont Hospital for Children
Box 269
Wilmington, DE 19899
Key words: Pulmonologist, exposure, pregnant, radiological studies

1

I. Introduction
Almost every practicing physician is aware that the utilization of diagnostic radiological
techniques and radiation therapy utilizing ionizing radiation has increased substantially over the
past 30 years.1 In 1980 the USA population received 20% of their exposure to ionizing radiation
from medical care. The National Council on Radiation Protection (NCRP) No. 160 (2009)
reported that almost 50% of the population’s radiation exposure came from medical care.
Unfortunately, this increased exposure has been presented in the newspapers, television and
internet and in many instances the risks of birth defects, miscarriage and cancer have been
exaggerated and the benefits ignored. It is important for physicians to become as knowledgeable
about the risks of ionizing radiation as they are about its benefits. Although pulmonologists do
not concentrate their practice on pregnant women or women of reproductive age, these patients
will be part of their practice. An important concern is that many women will visit their physician
and not know they are pregnant, or worse, will become pregnant between the time of the office
visit and the appointment for the radiological exam. These situations can be concerning for the
patient and the physician. In order for the physician to interpret the various forms of exposure
measurement Table 1 lists the various nomenclatures for radiation exposures so that the reader
will be able to understand radiation exposures in the terms with which they may be familiar.
Pulmonologists are fortunate with regard to the specific studies they request in order to
provide clinical care, since most of the diagnostic tests do not directly expose the uterus (embryo)
or ovary. Radiography of the chest, head, neck, dental or extremity exposes the embryo or ovary
to miniscule (insignificant) exposures of radiation. In some instances there is no exposure at all.
The pulmonologist may infrequently order diagnostic studies for a patient that exposes
the abdomen or pelvis but should be aware of other studies that could have been ordered by other
providers. Fortunately, the vast majority of diagnostic studies exposing the abdomen or pelvis
expose the embryo or ovary to less than 10 rad (0.1 Gy)

II. The reproductive and developmental risks of exposures of ionizing radiation to
pregnant or potentially pregnant women.
The reproductive and developmental risks of in utero exposures to ionizing radiation are
listed below (Tables 2 and 3)
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1) Birth defects, mental retardation, other neurobehavioral effects, growth retardation and
embryonic death (miscarriage) are deterministic effects (Threshold effects). This indicates that
these effects have a NOAEL (no adverse effect level). Almost all diagnostic radiological
procedures provide exposures that are below the NOAEL for these developmental effects.
Diagnostic radiological studies rarely exceed 10 rad (0.1 Gy), while the threshold for congenital
malformations or miscarriage is > 20 rad (0.2 Gy). (Table 2).
2) In order for the embryo to be deleteriously affected by ionizing radiation when the
mother is exposed to a diagnostic study, the embryo has to be exposed above the NOAEL to
increase the risk of deterministic effects. This rarely happens when pregnant women have x-ray
studies of the head, neck, chest or extremities.
3) During the pre-implantation and pre-organogenesis stages of embryonic development
the embryo is least likely to be malformed by the effects of ionizing radiation because the cells of
the very young embryo are omnipotent and can replace adjacent cells that have been deleteriously
affected. This early period of development has been designated as “the all or none period.”
4) Protraction and fractionation of exposures of ionizing radiation to the embryo decrease
the magnitude of the deleterious effects of deterministic effects. The more protracted or
fractionated the radiation the lower the risk because the threshold increases.
5) The increased risk of cancer following high level of exposures to ionizing radiation
exposure in adult populations has been demonstrated in the survivors of atomic bomb. Radiationinduced carcinogenesis is assumed to be a stochastic effect (nonthreshold effect) so that there is
theoretically a risk at low exposures. While there is no question that high-level exposures of
ionizing radiation can increase the risk of cancer, the magnitude of the risk of cancer from
embryonic exposures following diagnostic radiological procedures is controversial. Recent
publications and analyses indicate that the risk is lower for the irradiated embryo than the
irradiated child, which surprised many scientists interested in this subject (Tables 4- 6)2.

III. Evaluating the risks of radiation exposure to the developing embryo
When evaluating the risks of ionizing radiation, the physician is faced with several
different clinical situations:
Situation 1
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The pulmonologists are very fortunate because the radiological tests that would be
ordered for their patients will not expose the embryo directly and therefore the embryo will not
receive an exposure that would increase the embryo’s risk for birth defects, miscarriage, growth
retardation, mental retardation or neural behavioral effects (Table 7). Table 7 lists many
frequently used diagnostic radiological and radionuclide tests. Note that none of the tests exceed
exposures of 10 rad (0.1 Gy or 100 mGy) except for radiation therapy or extensive fluoroscopy to
the abdomen or pelvis.
Although most diagnostic radiological studies of the abdomen or pelvis do not expose the
embryo to more than 10 rad (0.10 Gy), the family is upset because they are aware that the embryo
was directly exposed. Under these circumstances it may be necessary to request the Health
Physicist to calculate the actual exposure in order to be able to allay the family’s concern with the
actual exposure.
Situation 2
The pregnant patient presents with clinical symptoms that need to be evaluated. What is
the appropriate utilization of diagnostic radiological procedures that may expose the embryo or
fetus to ionizing radiation?
A pregnant or possibly pregnant woman complaining of chest symptoms that cannot be
attributed to pregnancy deserves the appropriate studies to diagnose and treat her clinical
problems, including radiological studies. Furthermore, these studies should not be relegated to
one portion of the menstrual cycle if she has not yet missed her period. The studies should be
performed at the time they are clinically indicated whether or not the woman is in the first or
second half of the menstrual cycle. During the 2nd half of the menstrual cycle the pregnancy test
may be negative even though the patient is pregnant. This should be explained to the patient and
family.
Situation 3
A patient has completed a diagnostic procedure that has exposed her uterus to ionizing
radiation. Her pregnancy test result was negative. She believes she was pregnant at the time of
the procedure. What is your response to this situation?
Explain that you would have proceeded with the necessary radiological diagnostic test
whether the patient was pregnant or not because diagnostic studies that are indicated in the
patient have to take priority over the possible risk to her embryo; however, almost 100% of

4

diagnostic studies do not increase the risks to the embryo (Table 1). Second, she must have been
very early in her pregnancy because her pregnancy test result was negative. At this time, obtain
the calculated dose to the embryo and determine her stage of pregnancy. If the dose is below 10
rad (0.1 Gy; 0.1 Sv), you can inform the patient that her risks for birth defects and miscarriage
have not been increased. In fact, the threshold for these effects is 20 rad (0.2Gy) at the most
sensitive stage of embryonic development (Table 2). Of course, you are obligated to tell her that
every healthy woman is at risk for the background incidence of birth defects and miscarriage,
which is 3% for birth defects and 15% for miscarriage (Table 3).
Situation 4
A woman delivers a baby with serious birth defects. On her first postpartum visit, she
recalls that she had a diagnostic X-ray study early in her pregnancy. What is your response when
she asks you whether the baby's malformation could be caused by the radiation exposure?
In most instances, the nature of the clinical malformations will rule out radiation
teratogenesis (microcephaly, mental retardation and fetal growth retardation). In such a case, a
clinical teratologist or radiation embryologist could be of assistance. On the other hand, if the
exposure is below 10 rad (0.1 Gy), it would not be scientifically supportable to indicate that the
radiation exposure was the cause of the malformation. The threshold for malformations is 20 rad
(0.20 Gy) (Table 2). The dose, timing, and nature of the malformation are considered in this
analysis.
To appropriately and more completely respond to these questions, the physician should
rely on the extensive amount of available information on the effects of radiation on the embryos.
In fact, there is no environmental hazard that has been more extensively studied or on which
more information is available (Tables 2 and 4).3-12

IV. Radiation risks to the embryo
An acute exposure to ionizing radiation more than 50 rad represents a significant risk to
the embryo, regardless of the stage of gestation. 6-9, 12, 13 The threshold dose for low energy
transfer ionizing radiation that results in an increase in malformations is approximately 20 rad
(0.2 Gy) (Table 2). Although congenital malformations are unlikely to be produced by radiation
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during the first 14 days of human development, there would be a substantial risk of embryonic
loss if the dose is high. From approximately the 18th day to the 40th day postconception, the
embryo would be at risk for an increased frequency of anatomic malformations if the radiation
exposure exceeds 20-25 rad (0.2-0.25 Gy). Until about the 15th week, the embryo has an
increased susceptibility to central nervous system (CNS) effects, major CNS malformations early
in gestation and mental retardation in midgestation. Of course, with very high doses, in the
hundreds of rads, mental retardation can occur in the later part of gestation. Although it is true
that the embryo is vulnerable to the deleterious effects of these midrange exposures of ionizing
radiation, the measurable effects fall off rapidly as the exposure approaches the usual levels that
the embryo receives from diagnostic radiologic procedures (<10 rad; 0.1 Gy). The threshold of
20 rad (0.2 Gy) at the most vulnerable stage of development (20-25 days post conception) is
increased by protraction of the radiation exposure. If a pregnant woman had a series of
radiographic analyses over a period of three to four days that totaled 15 rad (0.15 Gy), there
would be no increased risk for any of the developmental threshold (deterministic) effects.6,12,13
The recommendations of most radiation embryologists indicate that exposures in the diagnostic
range will not increase the risk of birth defects or miscarriage.6.8.9.12 Table 4 compares the
spontaneous risks facing an embryo at conception and the risks from a low exposure of ionizing
radiation (10 rad; 100 mGy 10,000 mrad).
Therefore, the hazards of exposures in the range of diagnostic roentgenology (20-10,000
mrad [0.2mGy-0.1 Gy]) present an extremely low risk to the embryo when compared with the
spontaneous mishaps that can befall human embryos (Table 3 and 4). Approximately 30-40 % of
human embryos abort spontaneously (many abort before the first missed menstrual period) Table
3. Human infants have a 3 % major malformation rate at term that increases to approximately 6%
to 8 % once all minor malformations are recorded. Although doses of 1-3 rad (0.01-0.03 Gy) can
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produce cellular effects and the fact that diagnostic radiation exposure during pregnancy has been
associated with malignancy in childhood, the maximum theoretical risk to human embryos
exposed to doses of 10 rads or less is extremely small. When the data and risks are explained to
the patient, the family with a wanted pregnancy invariably continues with the pregnancy.
A frequent difficulty is that the risks from diagnostic radiation are evaluated outside the
context of the significant normal risks of pregnancy. Furthermore, many physicians approach the
evaluation of diagnostic radiation exposure with either of two extremes: a cavalier attitude or
panic. The usual procedures in clinical medicine are ignored, and an opinion based on meager
information is given to the patient. Frequently, this attitude reflects the physician's bias about
radiation effects or his or her ignorance of radiation biology. We have patient records in our files
of scores of patients who were not properly evaluated but were advised to have an abortion
following radiation exposure. The following case history is an example.
V. Case report
A 33 year old woman was diagnosed with breast cancer and radiation therapy of the
breast was initiated. Four weeks into her therapy it was discovered that she was 11 weeks
pregnant. The oncologist, radiation therapist and surgeon all encouraged the future mother and
family to abort the pregnancy. She already had received 3800 rads (3.8 Gy) to the breast. The
family asked for another opinion and our counseling service was contacted. The health physicist
at the consultee institution had calculated that the fetus had received 50 rads over a period of
almost 4 weeks. On each day of therapy the fetus had received 0.9 rad. Each week the fetus had
2 days without being exposed. The future mother’s physicians still suggested a therapeutic
abortion, but with less certainty. They asked me what I would tell her. I said that “I would not tell
her anything. I wanted to talk with her.”
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When we were able to talk, she immediately asked what should I do? I responded, “Do
you have any questions? She asked, “Could my baby be malformed”? I told her that 3 % of
babies are malformed. That is the background incidence, but in her case the fetus’s risks for
major birth defects were not increased for two reasons. The radiation was initiated in the seventh
week after all the organs had formed and more important the dose each day was too low to
produce malformations at any stage of pregnancy. Then she asked whether her baby could be
severely mentally retarded. I answered her in the negative. But I also had to tell her that one in
200 children is born mentally retarded. She then asked whether the baby could be growth
retarded. I responded that 4% of newborns are growth retarded, but that the radiation exposure
would not cause significant growth retardation. Finally, she asked, could my baby be normal? I
said, “Yes.”
The mother decided to keep the pregnancy and she delivered a 6 pound 11 ounce baby
boy who was physically normal and has been developing, according to the mother, “very
normally.”

VI. Evaluating the patient
Case histories are transmitted to our laboratory frequently. In 2008, we had 2,200,000
hits on our pregnancy website of the Health Physics Society, “Ask the Expert”. There were
760,000 downloads and 1646 direct consultations. In most instances the dose to the embryo is <
10 rads (0.1 Gy) and frequently is < 1 rad (.01 Gy). Our experience has taught us that there are
many variables involved in radiation exposure to a pregnant or potentially pregnant woman.
Therefore, there is no routine or predetermined advice that can be given in this situation.
However, if the physician takes a systematic approach for the evaluation of the possible effects of
radiation exposure, he/she can help the patient make an informed decision about continuing the
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pregnancy. This systematic evaluation can begin only when the following information has been
obtained:
•

Stage of pregnancy at the time of exposure

•

Menstrual history

•

Previous pregnancy history

•

Family history of congenital malformations, miscarriages

•

Other potentially harmful environmental factors during the pregnancy

•

Ages of the mother and father

•

Type of radiation study, dates and number of studies performed

•

Calculation of the embryonic exposure by a medical physicist or competent
radiologist

•

Status of the pregnancy: wanted or unwanted

The evaluation should be concluded, with both patient and counselor arriving at a
decision. The physician should place a summary of the following information in the medical
record. It should state that the patient has been informed that every pregnancy has a significant
risk of problems and that the decision to continue the pregnancy does not mean that the counselor
is guaranteeing the outcome of the pregnancy. The use of amniocentesis and ultrasound to
evaluate the fetus is an individual decision that would have to be made in each pregnancy.
Each consultation should include the following statement. “If you are healthy, young
(under 35) and have no personal or family history of reproductive or fetal developmental
problems, then you began this pregnancy with a risk of 3% for birth defects and 15% for
miscarriage. These are background risks faced by all pregnant women. Good luck with this
pregnancy and keep in touch.”

VII. The Carcinogenic effects of radiation
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The carcinogenic risks of in-utero radiation is an important topic that cannot be addressed
adequately in this article. In 1956, Stewart et al. (13) published the results of her case control
studies indicating the diagnostic radiation from pelvimetry was associated with a 50% increased
risk of childhood leukemia (Table 4). That would change the risk of childhood leukemia from 40
cases per million to 60 cases per million in the population of exposed fetuses. This has been a
very controversial subject. 12-17 SA recent publication by Preston et al. (2) presented data from the
in utero population of the A-bomb survivors which indicated that the embryo was less vulnerable
to the oncogenic effects of ionizing radiation than the child. It appears that the embryo is much
less vulnerable to the oncogenic effects of radiation than previous investigators have believed.
Patients can be told that the fetal risk is extremely small, so small that we cannot measure the
risks because such a large exposed population would be necessary (Tables 3, 4 and 5). Even if
one accepts the controversial concept that the embryo is more vulnerable to the carcinogenic
effects of radiation than the child, the risk at these low exposures is much, much smaller that the
spontaneous risks (1). Furthermore, other studies indicate that Stewart's (13) estimate of the risk
involved is exaggerated. 10-11, 15-17

VIII. Diagnostic or therapeutic abdominal radiation in women of reproductive age
In women of reproductive age, it is important for the patient and physician to be aware of
the pregnancy status of the patient before performing any type of X-ray procedure in which the
ovaries or uterus will be exposed. If the embryonic exposure will be 10 rad (0.1 Gy) or less, the
radiation risks to the embryo are very small when compared with the spontaneous risks (Tables
2-5). Even if the exposure is 10 rad (0.1 Gy), this exposure is far from the threshold or no-effect
dose of 20 rad. The patient will accept this information if it is offered as part of the preparation
for the radiological studies at a time when both the physician and patient are aware that a
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pregnancy exists or may exist. The pregnancy status of the patient should be determined and
noted.
Because the risks of 10-rad (0.1 Gy) fetal irradiation are so small, the immediate medical
care of the mother should take priority over the risks of diagnostic radiation exposure to the
embryo. Radiological studies that are essential for optimal medical care of the mother and
evaluation of medical problems that need to be diagnosed or treated should not be postponed.
Elective procedures such as employment examinations or follow-up examinations, once a
diagnosis has been made, need not be performed on a pregnant woman even though the risk to
the embryo is very small. If other procedures (e.g., magnetic resonance imaging or ultrasound)
can provide adequate information without exposing the embryo to ionizing radiation, then of
course they should be used. Naturally, there is a period when the patient is pregnant but the
pregnancy test is negative and the menstrual history is of little use. However, the risks of
exposure to 10 rad (0.1 Gy) or less are extremely small during this period of gestation (all or
none period,4 first two weeks). The patient will benefit from knowing that the diagnostic study
was indicated and should be performed in spite of the fact that she may be pregnant.

IX. Scheduling the examination
When elective radiological studies need to be scheduled, it is difficult to know whether to
schedule them during the first half of the menstrual cycle just before ovulation or during the
second half of the menstrual cycle, when most women will not be pregnant. The genetic risk of
diagnostic exposures to the oocyte or the embryopathic effects on the preimplanted embryo are
extremely small, and there are no data available to compare the relative risk of 10 rad (0.1 Gy) to
the oocyte or the preimplanted embryo. If the diagnostic study is performed in the first 14 days of
the menstrual cycle, the patient should be advised to defer conception for several months, based
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on the assumption that the deleterious effect of radiation to the ovaries decreases with increasing
time between radiation exposure and a subsequent ovulation? The physician is in a quandary
because he may be warning the patient about a very-low-risk phenomenon. On the other hand,
avoiding conception for several months is not an insurmountable hardship. This potential genetic
hazard is quite speculative for man, as indicated by the report by the NCRP and BEIR committee
report dealing with preconception radiation1, 6
“It is not known whether the interval between irradiation of the gonads and
conception has a marked effect on the frequency of genetic changes in human
offspring, as has been demonstrated in the female mouse. Nevertheless, it may be
advised for patients receiving high doses to the gonads (>25 rads) to wait for
several months after such exposures before conceiving additional offspring.” 3.
Because the patients exposed during diagnostic radiologic procedures absorb
considerably less than 25 rads, the recommendations made here may be unnecessary, but it
involves no hardship to the patient. Because both the NCRP and ICRP have previously
recommended that elective radiologic examinations of the abdomen and pelvis be performed
during the first part of the menstrual cycle (10-day rule, 14-day cycle) to protect the zygote from
possible but largely conjectural hazards, the recommendation to avoid fertilization of recently
irradiated ova perhaps merits equal attention.

X. Importance of determining pregnancy status of patient
If exposures less than 10 rads (0.1 Gy) do not measurably affect the exposed embryos,
and it is recommended that diagnostic procedures should be performed at any time during the
menstrual cycle, if necessary, for the medical care of the patient, then the question of expending
energy to determine the pregnancy status of the patient arises.
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There are several reasons why the physician and patient should share the burden of
determining the pregnancy status before performing a radiological or nuclear medicine procedure
that exposes the uterus:
1. If the physician is forced to include the possibility of pregnancy in the differential
diagnosis, a small percentage of diagnostic studies may no longer be considered necessary. Early
symptoms of pregnancy may mimic certain types of gastrointestinal or genitourinary disease.
2. If the physician and patient are both aware that pregnancy is a possibility and the
procedure is still performed, it is much less likely that the patient will be upset if she
subsequently proves to be pregnant.
3. The careful evaluation of the reproductive status of women undergoing diagnostic
procedures will prevent many unnecessary lawsuits. Many lawsuits are stimulated by the factor
of surprise. In some instances, the jury is not concerned with cause and effect but with the fact
that something was not done properly by the physicians. 18, 19 In this day and age, failure to
communicate adequately can be interpreted as less-than-adequate medical care. Both these
factors are eliminated if the patient's pregnancy status has been evaluated properly and the
situation discussed adequately with the patient. Physicians are going to have to learn that
practicing good technical medicine may not be good enough in a litigation-prone society. Even
more important, the patient will have more confidence if the decision to continue the pregnancy
is made before the medical radiological procedure is performed, because the necessity of
performing the procedure would have been determined with the knowledge that the patient was
pregnant. In every consultation dealing with the exposure of the embryo to diagnostic studies
involving ionizing radiation (radiography, computed tomography, use of radionuclides) in which
the reproductive risks or developmental risks for a fetus have not been increased by the radiation
exposure, the patient should be informed that every healthy woman with a negative personal and
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genetic family reproductive history has background reproductive risks which are 3% for birth
defects and 15% for miscarriage. these background risks cannot be changed.

14

References
1.

National Council on Radiation Protection and Measurements: Ionizing Radiation
Exposure of the Population of the United States. Report No. 160. Washington, DC:
NCRP 2009.

2.

Preston DL, Cullings H, Suyama A, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama
K, Kasagi F, Shore RE. Solid cancer incidence in atomic bomb survivors exposed in
utero or as young children. J Natl Cancer Inst 2008;100:428-436.

3.

Committee on the Biological Effects of Ionizing Radiation: BEIR VII Report: The
Effects on Populations of Exposure to Low Levels of Ionizing Radiation, pp 1-524.
Washington, DC: National Academy of Science Press, 2005.

4.

National Council on Radiation Protection and Measurements: Basic Radiation Criteria,
Report No. 39. Washington, DC: NCRP, 1971.

5

Brent RL. Radiations and other physical agents. In Wilson JG, Fraser FC, editors.
Handbook of Teratology, Vol 1. New York: Plenum Press, 1977 p. 153-223.

6

Brent RL. Utilization of developmental basic science principles in the evaluation of
reproductive risks from pre- and postconception environmental radiation exposures.
Paper presented at the Thirty-third Annual Meeting of the National Council on Radiation
Protection and Measurements. The Effects of Pre- and Postconception Exposure to
Radiation, April 2-3, 1997, Arlington, Virginia. Teratology 1999; 59:182-204.

7.

Brent RL. The effects of embryonic and fetal exposure to x-rays and isotopes. In: Barron,
W.M. and Lindheimer, M.D. editors. Medical Disorders During Pregnancy, 3rd Edition.
St. Louis: Mosby-Yearbook, Inc.; 2000, p. 586-610.

15

8.

National Council on Radiation Protection and Measurements: Medical Radiation
Exposure of Pregnant and Potentially Pregnant Women, Report No. 54, Washington, DC:
NCRP, 1977 p. 1-32.

9.

Mettler FA, Jr, Brent RL, Streffer C, Wagner L. Pregnancy and Medical Radiation. In
Valentin J, editor. Annals of the International Commission on Radiological Protection
(ICRP). Publication 84, Tarrytown, NY, Elsevier Science Inc., Vol. 30(1), 2000.

10.

Court Brown W M, Doll, R, Hill, A B. Incidence of leukemia after exposure to diagnostic
radiation in utero. British Medical Journal, November 26, 1960: 1539-1545.

11.

Brent RL. Lauriston S. Taylor Lecture: Fifty Years of Scientific Research: The
Importance of Scholarship and the Influence of Politics and Controversy. Health Physics
2007;93(5):348-379.

12.

Brent RL. Saving lives and changing family histories: Appropriate counseling of pregnant
women and men and women of reproductive age, concerning the risk of radiation
exposures during and before pregnancy. Am J Obstet Gynecol 2009;200(1):4-24.

13.

Stewart A, Webb D, Giles D, et al. Malignant disease in childhood and diagnostic
irradiation in utero. Lancet 1956; 2:447.

14.

McMahon B, Hutchinson GB. Prenatal X-ray and childhood: A review. Acta Unio. Int.
Contra Cancrum 1964; 20:1172.

15.

Boice JD Jr, Miller RW. Childhood and adult cancer after intrauterine exposure to
ionizing radiation. Teratology 1999; 59(4):227-233.

16.

Wakeford R, Little MP. Risk coefficients for childhood cancer after intrauterine
irradiation: a review. Int. J. Radiat. Biol. 2003;79:203-209.

17.

Brent RL. The effect of embryonic and fetal exposure to X-ray, microwaves, and
ultrasound: Counseling the pregnant and non-pregnant patient about these risks.
Seminars in Oncology 1989;16:347-369.

16

18.

Brent RL. Litigation-produced pain, disease and suffering: An experience with
congenital malformation lawsuits. Teratology 1977;16:1-14.

19.

Rugh R. Low levels of x-irradiation and he early mammalian embryo. Amer. J.
Roentgenol. 1962;87:559-566.

17

Table 1
Ionizing radiation Exposure Terminology*
rad (rem)

millirad; millirem

Gray (Gy)

Sievert (Sv)

0.001

1

0.01 mGy

0.01 mSv

0.01

10

0.1 mGy

0.1 mSv

0.1

100

1 mGy

1 mSv

1

1000

0.01 mGy

0.01 Sv

10

10,000

0.1 mGy

0.1 Sv

100

100,000

1 Gy

1 Sv

* The rad and the rem, and the Gray and Sievert are identical for exposures of low energy
transfer (LET) radiation, i.e, x-rays, gamma rays, beta rays, and protons. These forms of
radiation have a Relative Biological Effectiveness (RBR) rated at one. Exposures to alpha
rays and neutrons have a biological effectiveness greater than one. The rem and the
Sievcert take into consideration the RBE of the radiation. For clinicians, the RBE is
infrequently relevant, because most radiological procedures utilize radiation with an RBE
of 1 so the Gray and Sievert exposures will be identical.
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Table 2. Radiation effects at different stages of gestation*
Stage, Gestation Weeks

Effect

First and second weeks post last

First two weeks post first day of the last menstrual period. This is

menstrual period.(LMP) (Prior to

preconception radiation. Mother has not yet ovulated

conception)
Third and fourth week of gestation

Minimum human acute lethal dose (from animal studies).

(First two weeks post conception)

Approximately 0.15-0.20 Gy. Most sensitive period for the induction
of embryonic death. No increase risk of malformations in surviving
fetuses. “All or none stage”

Fourth to eighth week of gestation

Minimum lethal dose (from animal studies). At 18 day post

(Second to sixth week post

conception = 0.25 Gy (25 rad). After 50 days post conception >0.50

conception)

Gy (50 rad).
Embryo is vulnerable to the induction of major malformations.
Threshold for malformations > 0.2 Gy to 0.5 Gy, depending on the
malformation.
Minimum dose for growth retardation. At 18-36 days = 0.20-0.50 Gy
(20 rad-50 rad). At 36-110 days = 0.25-0.50 Gy.(25 to 50 rad) But
the induced growth retardation during this period is not as severe as
during mid-gestation (8-15 wks) from similar exposures and is more
recuperable (Rugh, 1962).

Eighth to fifteenth week of

Most sensitive period for irreversible whole body growth retardation,

gestation

microcephaly and severe mental retardation. Threshold for severe
metal retardation is0.35 to 0.50 Gy (35-50 rad). Miller believes the
threshold is > 0.5 Gy. Decrease in I.Q can occur at lower exposures.

Sixteenth week to term of gestation

Higher exposures can produce growth retardation and decreased
brain size and intellect, although the effects are not as severe as
occurs from similar exposures during mid-gestation. No documented
risk for major anatomical malformations. Minimum lethal dose
threshold for mental retardation (from animal studies) from 15 weeks
to term > 1.5 Gy (150 rad) but decrease in I.Q. can occur at lower
exposures

*

Radiation exposure and risk at different gestational phases. There is no evidence that radiation exposure

in the diagnostic ranges (<0. 10 Gy, <10 rad) is associated with measurably increased incidence of
congenital malformation, stillbirth, miscarriage, growth retardation or mental retardation.
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Table 3 Reproductive risks per million recognized pregnancies
Reproductive Risks
Immunologically & clinically diagnosed spontaneous abortions per million conceptions (< 20%

Frequency
350,000

has lethal malformations or chromosome abnormalities that cause abortion before the first month
of gestation).
Clinically recognized spontaneous abortions per million clinically recognized pregnancies.

150,000

Spontaneous abortion after the first missed menstrual period.
Genetic Diseases per million births

110,000

Multifactoral or polygenic genetic environmental interactions)

90,000

Dominantly inherited disease

10,000

Autosomal and sex-linked genetic disease

1,200

Cytogenetic (chromosomal abnormalities)

5,000

New mutations in the developing ova or sperm prior to conception

3,000

Major malformations (genetic, unknown, environmental)

30,000

Prematurity (Ireland 55,000; United States 124,000

69,000

Fetal growth retardation

30,000

Stillbirths (>20 wk.)

4,000-20,900

Infertility

7% of couples

Brent 1999
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Table 4
Risk of 10 rad (0.1 Gy) to Embryo*
Risk
Risk of very early pregnancy loss,
before, the first missed period

350,000/106 pregnancies

Additional risk of 10
rad (0.1 Gy) exposure
0

Risk of spontaneous abortion in a
known pregnant women
Risk of major congenital
malformations
Risk of severe mental retardation
Risk of childhood leukemia/year

150,000/106 pregnancies

0

Risk of early- or late-onset genetic
disease
Prematurity
Growth retardation
Stillbirth
Infertility

Background Incidence

30,000/106

0

5,000/106
40/106 /year

0
Very low increased
risk, and possibly no
measurably
identifiable increased
risk
Very low risk is in
next generation
0
0
0
0

100,000/106
69,000/106 pregnancies
30,000/106 pregnancies
20-2000/106 pregnancies
7% of couples
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Table 5
Follow-up of adults with solid cancers in Hiroshima and Nagasaki who were in
utero at the time of detonation of the A-bombs in 1945
Results published in March 2008 (Preston et al 2008)
Dose in Sv (rads)

No. of patients

No. of

Person years

Cancers

% with solid
Cancers

<0.005 (<0.5)

1547

54

49,326

3.5

0.005-<0.1 (0.5 to 10)

435

16

14,005

3.7

0.1 to <0.2 (10 to <20)

168

6

5041

3.6

0.2 to <0.5 (20 to <50)

172

8

5496

4.6

0.5 to <1.0 (50 to <100)

92

7

2771

7.6

>1.o

48

3

1404

6.2

Total

2452

94

94

3.5
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Table 6
Follow-up of adults with solid cancers in Hiroshima and Nagasaki who were in children at the time of
detonation of the A-bombs in 1945
Results published in March 2008 (Preston et al 2008)
Dose in Sv (rads)

No. of patients

No. of

Person years

% of Cancers

Cancers
<0.005 (<0.5)

8549

318

247,744

3.7

0.005-<0.1 (0.5 to 10)

4528

173

134,621

3.8

0.1 to <0.2 (10 to <20)

853

38

25,802

4.4

0.2 to <0.5 (20 to <50)

859

51

25,722

5.9

0.5 to <1.0 (50 to <100)

325

21

9522

6.5

>1.0

274

48

7620

17.5

Total

15388

649

451,031

4.2
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Table 7. Typical doses for selected medical procedures
Type

Description

Embryo/Fetal
Dose Range (mGy)

Gonadal Dose
(mGy) (Ovaries,
Testes)

x-ray

Skull

<0.01

<0.01, <0.01

x-ray

Chest

<0.01

<0.01, <0.01

x-ray

Thoracic spine

<0.01

<0.01, <0.01

x-ray

Mammography

<0.01

<0.01, <0.01

x-ray

Barium meal

0.1-1.1

x-ray

Pelvis

0.1-1.1

1.2, 4.6

x-ray

Lumbar spine

1-2

4.3, 0.6

x-ray

Abdomen

1-3

2.2, 0.4

x-ray

Barium enema

7-8

16, 3.4

CT

Chest /CTPA

0.1-1

0.08, <0.01

CT

Abdomen

4-16

8.0, 0.7

CT

Pelvis

10-32

23, 1.7

Chest fluoroscopy

Chest

<0.1 mGy/min

IR fluoroscopy

Abdominal fluoro

6 mGy/min

Nuc Med

Lung ventilation

0.1-0.3

0.13-0.5, 0.13-0.5

Nuc Med

Lung perfusion

0.1-0.4

0.06-0.27, 0.04-0.16

Nuc Med

White cell scan

0.7-1.4

Nuc Med

Renal scan

3-7

1.0-2.0, 0.7-1.4

Nuc Med

Bone scan

4.5-7

2.7-4.0, 1.8-2.7

Nuc Med

Cerebral blood flow

5-10

3.7-7.3, 1.3-2.7

Nuc Med

PET

8-16

5.6-11.1, 4.4-8.8

Nuc Med

Myocardial
perfusion

16.7-22.2

9.3-12.4, 2.7-3.6

Nuc Med

Therapy

>50

31, 19

24

